Trademark Overview
On Monday, May 20, 2024, a trademark application was filed for CIMBAN with the United States Patent and Trademark Office. The USPTO has given the CIMBAN trademark a serial number of 98558902. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 20, 2024. This trademark is owned by Camena Bioscience Limited. The CIMBAN trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Chemicals for use in the biochemical and chemical industry; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; active chemical ingredients; DNA, RNA, XNA, genes, oligonucleotides and proteins; nucleic acids comprising synthetic nucleotides; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; chemical preparations namely synthetic enzymes, gene editing enzymes, DNA, RNA, XNA, genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA for scientific and medical research; synthetic DNA, RNA, XNA, genes, oligonucleotides and proteins for use in medical biologics and therapeutics; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins.
Consultancy in relation to biochemistry and biotechnology; research and development in the field of biotechnology and synthetic biology; biological analysis; biotechnological research relating to enzymatic synthesis; provision of gene synthesis solutions; provision of development and test of enzyme production methods; evaluations, estimates, research and reports in the field of enzymatic production; services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; production of nucleic acid sequences; research and development into the creation of synthetic nucleic acid sequences; design, build and testing of synthetic gene sequences; design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; design, build and testing of synthetic gene sequences services of labora...
